Your browser doesn't support javascript.
loading
Correction to: New CEACAM-targeting 2A3 single-domain antibody-based chimeric antigen receptor T-cells produce anticancer effects in vitro and in vivo.
Jancewicz, Iga; Smiech, Magdalena; Winiarska, Magdalena; Zagozdzon, Radoslaw; Wisniewski, Pawel.
Affiliation
  • Jancewicz I; 4Cell Therapies S.A., 59C Bojkowska Street, 44-100, Gliwice, Poland.
  • Smiech M; 4Cell Therapies S.A., 59C Bojkowska Street, 44-100, Gliwice, Poland.
  • Winiarska M; 4Cell Therapies S.A., 59C Bojkowska Street, 44-100, Gliwice, Poland.
  • Zagozdzon R; Department of Immunology, Medical University of Warsaw, 5 Nielubowicza St., Building F, 02-097, Warsaw, Poland.
  • Wisniewski P; Laboratory of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, 5 Pawinskiego Str., 02-106, Warsaw, Poland.
Cancer Immunol Immunother ; 73(9): 184, 2024 Jul 05.
Article in En | MEDLINE | ID: mdl-38969928
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cancer Immunol Immunother Journal subject: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Year: 2024 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cancer Immunol Immunother Journal subject: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Year: 2024 Document type: Article Affiliation country: